The Role of Personality Functioning on Early Drop out in Outpatient Substance Misuse Treatment

Papamalis, Fivos; Dritsas, I.; Knight, Kevin

doi:10.1080/10826084.2021.1908358

Cited by 4 publications

(2 citation statements)

References 87 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Personality functioning has been advanced as an indicator for clinical decision making ( 28 , 96 , 97 ). Our data do indeed suggest a systematic selection of patients with poorer personality functioning to treatment with longer duration.…”

Section: Discussionmentioning

confidence: 99%

Improvement of personality functioning among people treated within personality disorder mental health services. A longitudinal, observational study

Kvarstein,

Frøyhaug,

Pettersen

et al. 2023

Front. Psychiatry

View full text Add to dashboard Cite

ObjectiveEvidence-based personality disorder (PD) treatments are dominated by interventions targeting Borderline PD, although clinical populations characteristically include different PD features and severity. Personality functioning is a new concept intended to capture common features across PDs. This study aimed to investigate longitudinal improvement of personality functioning in a clinical sample assigned to PD treatment.MethodAn observational, large, longitudinal study of patients in PD treatments on specialist mental health service levels (N = 1,051). DSM-5 PDs were systematically assessed on referral. Personality functioning was repeatedly assessed (LPFS-BF-2.0), supplemented by symptom distress (anxiety: PHQ-GAD-7, depression: PHQ-9), and social/occupational activity (WSAS, work/study activity). Statistics were linear mixed models.ResultsThirty per cent had personality difficulties below PD threshold. Among PDs, 31% had Borderline (BPD), 39% Avoidant (AvPD), 15% not otherwise specified, 15% other PDs, and 24% > one PD. More severe initial LPFS-BF was associated with younger age, presence of PD and increasing number of total PD criteria. Across PD conditions, LPFS-BF, PHQ-9 and GAD-7 improved significantly (overall effect size 0.9). Mean duration of PD treatment was 15 (SD 9) months. Drop-out rates were low (12%). LPFS-BF improvement-rates were higher for BPD. Younger age was moderately associated with slower PHQ-9 improvement. Work/study activity was initially poor, poorer levels associated with AvPD and younger age, and improvement was non-significant across PD conditions. AvPD was associated with slower WSAS improvement-rates.ConclusionPersonality functioning improved across PD conditions. The results highlight BPD improvements. The study points to challenges concerning AvPD treatment, poor occupational activity and age-related differences.

show abstract

Section: Discussionmentioning

confidence: 99%

Improvement of personality functioning among people treated within personality disorder mental health services. A longitudinal, observational study

Kvarstein,

Frøyhaug,

Pettersen

et al. 2023

Front. Psychiatry

View full text Add to dashboard Cite

show abstract

“…As reported in literature, risk factors of early drop out include: young age (Calvo et al , 2018); low education or unemployment (Calvo et al , 2018; King and Canada, 2004; Masaki and Toyomasu, 2010); female gender (Calvo et al , 2018; King and Canada, 2004; Masaki and Toyomasu, 2010); being divorced/without a familiar or social support (Calvo et al , 2018; Masaki and Toyomasu, 2010); and the absence of alcohol/substance-related physical complications (Masaki and Toyomasu, 2010). Moreover, patients’ personality functioning, including affective instability, social dysfunction and low aggression regulation (Papamalis et al , 2021), and high levels of craving (Ledda et al , 2019) are considered potential determinants of early drop out.…”

Section: Discussionmentioning

confidence: 99%

Aripiprazole once monthly as a maintenance treatment for patients with schizophrenia and alcohol/substance use disorder: an observational, real-world study

Chiappini,

Mosca,

Miuli

et al. 2023

ADD

View full text Add to dashboard Cite

Purpose This paper aims to investigate the role of aripiprazole once monthly as a maintenance treatment in a sample of patients with schizophrenia comorbid with alcohol and substance use disorder (AUD/SUD). Design/methodology/approach A sample of 24 Italian adult patients has been recruited and treated with aripiprazole once monthly after clinical stabilization with oral aripiprazole during May 2021 and June 2022. Clinical evaluations have been performed at the baseline (T0) and after 12 (T1) and 24 (T2) weeks. Findings During the study period, an improvement of both the clinical condition and general health from baseline was observed, as well as a reduction of craving for alcohol/substances. However, from T0, the number of patients who continued with this study decreased at T1 (n = 8) and then at T2 (n = 4). No serious adverse events were reported, including changes in weight, lipid/glucose metabolism, electrocardiogram and extra-pyramidal side effects. Originality/value Although limited by the high number of drop outs, this observational real-world study provided insights into the use of aripiprazole once monthly among a sample of patients with schizophrenia and comorbid SUD/AUD. Further studies of longer duration and on a larger sample are needed.

show abstract

Severity of anabolic steroid dependence, executive function, and personality traits in substance use disorder patients in Norway

Scarth

Havnes

Jørstad

et al. 2022

Drug and Alcohol Dependence

View full text Add to dashboard Cite

The Role of Personality Functioning on Early Drop out in Outpatient Substance Misuse Treatment

Cited by 4 publications

References 87 publications

Improvement of personality functioning among people treated within personality disorder mental health services. A longitudinal, observational study

Improvement of personality functioning among people treated within personality disorder mental health services. A longitudinal, observational study

Aripiprazole once monthly as a maintenance treatment for patients with schizophrenia and alcohol/substance use disorder: an observational, real-world study

Severity of anabolic steroid dependence, executive function, and personality traits in substance use disorder patients in Norway

Contact Info

Product

Resources

About